Rosengarten M D, Portnoy D, Chiu R C, Paterson A K
Can Med Assoc J. 1985 Aug 15;133(4):279-83.
Cardiac pacemakers are part of a growing group of expensive implantable electronic devices; hospitals in which 100 pacemakers are implanted per year must budget over $300 000 for these devices. This cost represents a considerable burden to health care resources. Since the "life-span" of modern pacemakers often exceeds that of the patients who receive them, the recovery and reuse of these devices seems logical. Pacemakers can be resterilized and tested with current hospital procedures. Reuse should be acceptable under Canadian law, but the manner in which the pacemakers are recovered and the patients selected should follow careful guidelines. Every patient should provide written informed consent before receiving a recovered pacemaker. Properly executed, reuse of pacemakers should provide a high level of health care while maintaining or reducing the cost of these devices.
心脏起搏器是越来越多的昂贵植入式电子设备的一部分;每年植入100个起搏器的医院必须为这些设备预算超过30万美元。这笔费用对医疗资源来说是相当大的负担。由于现代起搏器的“使用寿命”往往超过接受它们的患者的寿命,这些设备的回收和再利用似乎是合理的。起搏器可以通过当前的医院程序进行重新消毒和测试。根据加拿大法律,再利用应该是可以接受的,但起搏器的回收方式和所选患者应遵循严格的指导方针。每位患者在接受回收的起搏器之前都应提供书面知情同意书。如果执行得当,起搏器的再利用应在维持或降低这些设备成本的同时提供高水平的医疗服务。